Human papilloma virus specific immunogenicity and dysfunction of CD8+ T cells in head and neck cancer

Sri Krishna, Peaches Ulrich, Eric Wilson, Falguni Parikh, Pooja Narang, Shanshan Yang, Amelia K. Read, Seunghee Kim-Schulze, Jin Park, Marshall Posner, Melissa Wilson Sayres, Andrew Sikora, Karen Anderson

Research output: Contribution to journalArticle

13 Scopus citations


Human papillomavirus subtype 16 (HPV16) is the primary cause of an increasing number of head and neck squamous cell carcinomas (HNSCC), providing strong rationale for T-cell immune therapies against HPVþ HNSCC. Here we assess immunogenicity of HPV16-specific CD8þ T cells (CTL) and characterize HPV-specific mechanisms of T-cell dysfunction. We identified 16 strong and 29 moderately immunogenic CTL-epitopes from HPV16 E2, E6, and E7 antigens restricted by 12 common HLA class I alleles. E2-specific CTL-reactivity was higher in patients with HPVþ HNSCC than in healthy controls (>3-fold; P ¼ 0.026). Patient-derived E2, E6, and E7 peripheral CTLs exhibited heterogeneity in dysfunctional phenotypes. Immunoge-nomic analyses of 119 HNSCC transcriptomes revealed high T-cell infiltration and dysfunction in HPVþ HNSCC and correlation of HPV antigen expression with T-cell exhaustion gene signatures. Indoleamine 2,3-dioxygenase (IDO-1) was strongly expressed in HPVþ HNSCC versus HPV HNSCC (P ¼ 0.001) and correlated with E7 expression (R2 ¼ 0.84; P ¼ 0.033). Combination treatment with PD-1 blockade and IDO-1 inhibition overcame profound CTL-dysfunction, enhancing HPVþ HNSCC sensitivity to CTL-cytotoxicity in vitro (up to 10-fold in E7-CTLs, P ¼ 0.011). Our findings implicate mechanisms of T-cell escape in HPVþ HNSCC, wherein high tumoral HPV-antigen load results in high expression of immune dysfunction genes on tumor cells (e.g., IDO-1), and dysfunction of HPV-specific CTLs (e.g., E7, E2-CTLs). The HPV16 CTL-epitopes identified in this study, in combination with blockade of HPVþ HNSCC-specific PD-1/IDO-1 checkpoints, may be useful for targeted immunotherapy. Significance: This study evaluates the HPV antigen T-cell immunogenicity role of inhibitory receptors and other exhaustion markers in the cytotoxic function of HPV antigen-specific CTLs and identifies combined inhibition of PD-1/IDO-1 as a strategy to enhance CTL targeting of HPVþ HNSCC.

Original languageEnglish (US)
Pages (from-to)6159-6170
Number of pages12
JournalCancer Research
Issue number21
StatePublished - Nov 1 2018

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Human papilloma virus specific immunogenicity and dysfunction of CD8<sup>+</sup> T cells in head and neck cancer'. Together they form a unique fingerprint.

  • Cite this

    Krishna, S., Ulrich, P., Wilson, E., Parikh, F., Narang, P., Yang, S., Read, A. K., Kim-Schulze, S., Park, J., Posner, M., Wilson Sayres, M., Sikora, A., & Anderson, K. (2018). Human papilloma virus specific immunogenicity and dysfunction of CD8+ T cells in head and neck cancer. Cancer Research, 78(21), 6159-6170.